Full Length Research Paper
References
|
Andreu G (2012). Blood donation monitoring the risk of infection and transfusion safety. Weekly Epidemiology Bulletin, pp. 433-458. |
|
|
Bessimbaye N, Moussa AM, Mbanga D (2014). Seroprevalence of HBs Ag and of anti-HCV antibodies among HIV infected people in N'Djamena, Chad. Exototic Pathology Society Bulletin 107:327-331. |
|
|
Villar LM, de Oliverira JC, Cruz HM, Yoshida CF, Lampe E, Lewis-Ximenez LL (2011). Assessment of dried blood spot samples as a simple method for detection of hepatitis B virus markers. Journal Medicine Virology 83:1522-1529. |
|
|
Bottero J, Brouard C, Roudot-Thoraval F, Deuffic-Burban S, Hofliger P, Abergel A (2016). French guidelines for hepatitis B and C screening: A combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV. Liver International 36(10):1442-1449. |
|
|
Brouard C, Bousquet V, Leon L, Pioche C, Lot F, Semaille C et al. (2013). Incidence of acute symptomatic hepatitis B in France in 2010, LaboHep 2010 survey. Weekly Epidemiology Bulletin 19 :210-3. |
|
|
Brouard C, Pioche C, Leon L, Lot F, Pillonel J, Larsen C (2016). Incidence and modes of transmission of acute hepatitis B diagnosed in France, 2012-2014. Weekly Epidemiology Bulletin 13-14:237-243. |
|
|
Medical Committee for Exiles (COMEDE) (2012). The health of exiles, observation and activity report: 92 p. |
|
|
Denis F, Daddi G (2016). Vaccination against hepatitis B: evolution of vaccination coverage; impact on public health, limits of vaccination, new vaccines. Natle Médecine Academic Bulletin 200(1):33-45. |
|
|
Dhumeaux D, Delfraissy JF, Pageaux GP, de Lédinghen V (2014). Prise en charge des personnes infectées par les virus de l'hépatite B ou de l'hépatite C. Éditions EDK/Groupe EDP Sciences, Paris:1-537. |
|
|
European Association for the Study of the Liver (EASL) (2012). clinical practice guidelines: Management of chronic hepatitis B virus infection. Journal Hepatology 57:167‑85. |
|
|
European Association for the Study of the Liver (EASL) (2017). 2017 clinical practice guidelines on the management of hepatitis B virus infection. Journal Hepatology 67:370-398. |
|
|
European Centre for Disease Prevention and Control (ECDC) (2018). Hepatitis B. In: ECDC. Annual Epidemiological report for 2016: 10 p. |
|
|
French Society of Microbiology (SFM) (2015). Hepatitis B virus, In: REMIC: French Society of Microbiology Edition 2015:645-650. |
|
|
Gkouvatsos G, goossens N, Spahr L, Negro F (2017). Hépatite B: New management recommendations. Swiss Medicine Journal 13:1458-146363. |
|
|
High Authority for Health (HAS) (2012): |
|
|
National Institute of Public Health Quebec (INSPQ) (2014). Laboratory tests recommended for screening for hepatitis B virus infection. 89 p. |
|
|
Lange B, Cohn J, Roberts T, Camp J, Chauffour J, Gummadi N (2017). Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): Two systematic reviews and meta-analyses. BMC Infection Disease 17(Suppl 1):700. |
|
|
Laperche S, Servant-Delmas A, Gallien P, Pillonel J (2012). Surveillance of the diversity of HIV viruses, HBV, HCV in French blood donors between 2000 and 2010. Weekly Epidemiology Bulletin 39-40:447-452. |
|
|
Laporal S, Léon L, Pioche C, Vaux S, Pillonel J, Lot F, Brouard C (2019). Estimation of the number of acute hepatitis b diagnoses and exhaustivity of mandatory notification in France in 2016, labohep 2016 survey. Epidemiology Hebdomadary Bulletin 24-25:500-505. |
|
|
Lefrère JJ, Rouger P (2011). New practice of blood transfusion. Elsevier Masson, Paris. |
|
|
Médecins du Monde (MDM) (2011). Observatory for access to healthcare at the France mission. Report :218 p. |
|
|
Meffre C, Le Strat Y, Delarocque-Astagneau E, Dubois F, Antona D, Lemasson JM (2010). Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors; Journal Medicine Virology 82:446-55. |
|
|
Michele T, Gerolamo V, Bruno T (2011). Acridine dérivatives as anti-BVDV agents. Elsevier 91:133-141. |
|
|
Press archives (PA) (2014). Biological screening strategies for viral hepatitis B and C. |
|
|
Papatheodoridis G, Dalekos G, Sypsa V (2016). PAGE- B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy. Journal of Hepatology 64(4):800-806. |
|
|
Public Health England (PHE) (2017). Acute hepatitis B (England): annual report for 2016. London, Health Protection Report :13 p. |
|
|
Pillonel J, Legrand D, Laperche S (2012). Epidemiology of blood donors infected with HBV and HCV and residual risk of transmission of these infections by transfusion in France. Montpellier : 1st AFEF days: 7p. |
|
|
Polaris Observatory Collaborators (POC) (2018). Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study. Lancet Gastroenterolgy Hepatology 3(6): 383-403. |
|
|
Public Health Agency of Canada (ASPC) (2020). Main serological markers of viral hepatitis. Canadian guidelines for sexually transmitted diseases. |
|
|
Raffetti E, Fattovich G, Donato F (2016). Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis. Liver International 36:1239‑1251. |
|
|
Rahib D, Larsen C, Gautier A, Saboni L, Brouard C, Chevaliez S, Barin F, Lot F, Lydie N (2019). Acceptability and feasibility of home self-sampling for HIV, HBV and HCV testing in the general population in France in 2016: barotest study. Bulletin Epidemiology Hebdomadary 24-25:478-490. |
|
|
Registres (2015-2020). Service gastroenterology du CHURN: pp. |
|
|
RGPH 2 (2009) Deuxième Recensement Général de la Population et de l'Habitat. N'Djamena. INSEED 189 p. |
|
|
Richard J, Schaetti C, Basler S, Spicher VM (2017). Reduction of acute hepatitis B through vaccination of adolescents with no decrease in chronic hepatitis B due to immigration in a low endemicity country. Swiss Medicine Weekly 147:w14409. |
|
|
Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ (2015). Estimations of world-wide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386:1546‑1555. |
|
|
Syria L, Annabelle SD, Pierre G, Josiane Pl (2012). Monitoring the diversity of HIV, HBV and HCV viruses in French blood donors between 2000 and 2010. Weekly Epidemiology Bulletin:439-447. |
|
|
Vaux S, Laporal S, Pioche C, Mathias Bruyand M, Lévy-Bruhl D, Lot F, Brouard C (2019). Surveillance of acute hepatitis b through mandatory notification, France, 2003-2018. Bulletin Epidemiology Hebdomadary 24-25:491-499. |
|
|
World Health Organization (WHO) (2015). Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. |
|
|
World Health Organization (WHO) (2016). Global health sector strategy for viral hepatitis 2016-2021. Towards the elimination of viral hepatitis. Geneva. 55p. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
